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Sin BES among the various stents, showing a signiﬁcant correlation with positive
remodeling by intravascular ultrasound (r¼0.42, p¼0.047).
Conclusions: Differences in neointimal coverage as assessed by OCT in BMS, E-
ZES, EES and BES were found after 9-month implantation in STEMI patients. This
might cause differences in the development of stent thrombosis. Furthermore, E-ZES
might have potential to lead to early discontinuation of dual antiplatelet therapy
among these second-generation drug-eluting stents.Table 1: Differences related to QCA and OCT ﬁndings after 9-months implan-
tationamong BMS, E-ZES, EES and BES
BMS E-ZES EES BES
Restenosis rate :
QCA (%)
38.2 27.1 14.9yy,¤ 14.8xx,<
Target lesion
revascularization
rate (%)
13.6 4.8 0 0
Covered strut rate
(%)
98.4 99.0 93.7yy,¤¤ 96.4
Uncovered strut
rate (%)
0.17 0.18 3.58yy,¤¤ 0.99<
Malapposed rate
(%)
0.82 0 1.73¤¤ 1.77<<
Malapposed
covered rate
(%)
0.46 0 1.1¤ 1.73<<
Malapposed
uncovered rate
(%)
0.36 0 0.63y,¤¤ 0.05z
Tissue coverage
thickness (mm)
346.8 267.0 93.4yy,¤¤ 73.4xx,<<
Neointimal
coverage area
rate (%)
35.3 28.5 11.5yy,¤¤ 9.16xx,<<
Evagination/strut
rate (%)
0.8 0.02 2.45¤ 8.12xx,z,<<
yp<0.05 (BMS vs. EES); yy p<0.01 (BMS vs. EES); xx p<0.01 (BMS vs. BES); ¤ p<0.05 (E-ZES
vs. EES),¤¤ p<0.01 (E-ZES vs. EES); < p<0.05 (E-ZES vs. BES); << p<0.01 (E-ZES vs. BES); z
p<0.05 (EES vs. BES).TCT-557
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Background: The aim of this study is to explore the application of IVUS derived
parameters to act as a surrogate monitoring the absorption and degradation
process of a Paclitaxel-Eluting-Absorbable Magnesium Scaffold (DREAMS)
implanted in human coronary arteries. The ultrasonic changes of this scaffold are
assumed to have a strong relationship towards its degradation and bioresorption
process.
Methods: Serial IVUS data of the BIOSOLVE-I study was analysed by applying
differential echogenicity analyses, a method which previously showed that visual
changes of the ultrasonic appearance of bioresorbable scaffolds can be quantitatively
identiﬁed.
Results: In post-implantation IVUS images, the struts of the magnesium scaffold
appear as clearly visible and quantiﬁable hyperechogenic spots without, unlike
calciﬁed areas, causing any acoustic shadowing. Echogenicity analyses of pre- and
post-implantation scaffolded segments showed a signiﬁcant increase of %hyper-
echogenicity caused by the scaffold from 9 to 22% (p<0.001); respectively (Figure 1).
At 6 months the %hyperechogenicity decreased signiﬁcantly from 22 to 16%
(p<0.001). At further time points the scaffolded segments showed still a continuous
further decrease of %hyperechogenicity, however, leveling off to a non-signiﬁcant
change between 12 and 18 months, 13 vs. 12% (p¼0.5).B168 JACC Vol 62/18/Suppl B j October 27–NoveConclusions: The magnesium scaffold shows a continuous decrease of its ultrasonic
appearance over time and the quantitative differential echogenicity evaluation
supports that the DREAMS absorption is likely to be completed at 6-months.
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Background: Rotational atherectomy (RA) is an effective strategy for the modiﬁ-
cation of heavily calciﬁed coronary lesions, particularly those which balloon catheters
or imaging devices cannot cross. Identiﬁcation of extended superﬁcial calcium by
intravascular ultrasound (IVUS) has led to selected vessel modiﬁcation with RA to
facilitate stent delivery and expansion. We assessed the necessity of lesion prepara-
tion with RA for heavily calciﬁed stenoses identiﬁed by pre-procedural IVUS in
drug-eluting stent (DES) era.
Methods: From January 2010 through October 2012, 143 de novo severely calciﬁed
stenoses (deﬁned as calcium arc of >270 degrees as identiﬁed by pre-procedural
IVUS) in 143 patients were assigned to RA followed by stenting or stenting without
RA at the discretion of the operator. Angiographically documented calciﬁed lesions
that an IVUS catheter could not cross were excluded. IVUS morphometric analysis
was performed. Cardiac death, myocardial infarction, stent thrombosis, target lesion
revascularization (TLR) and target vessel revascularization (TVR) were assessed at
mid-term.
Results: RA was performed in 51/143 lesions (35.7%). Complete procedural success
was achieved in all cases. Second-generation DES was used in 121 cases (84.6%).
Patient and lesion characteristics were similar in both populations. Minimal lumen
area at post-procedure was larger in RA patients vs. non-RA patients (6.952.30mm2
vs. 6.061.86mm2, p¼0.02). No cardiac death and stent thrombosis occurred in either
population. There was no difference in myocardial infarction between RA patients and
non-RA patients (7.8% vs. 2.2%, p¼0.11). RA patients showed a trend of higher TLR
and TVR vs. non-RA patients (TLR: 19.6% vs. 9.8%, p¼0.097, TVR: 21.6% vs.
9.8%, p¼0.052). Multivariable logistic regression analysis showed chronic kidney
disease on hemodialysis to be the strongest independent predictor of TLR (OR, 5.86,
95% CI 1.93 -17.80, p¼0.002) and TVR (OR, 5.02, 95% CI 1.74-14.47, p¼0.003).
Conclusions: In conclusion, DES implantation without RA could be a default strategy
for severely calciﬁed lesions, even those with ring calciﬁcation, when IVUS assess-
ment is possible at pre-procedure.
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Background: Several observational studies have shown that tissue prolapse (TP)
lesions detected by intravascular ultrasound after stent implantation in coronary artery
diseases are not fatal phenomena. However data are lacking about their characteristics
and long term outcomes in patients with ST-segment elevation myocardial infarction
(STEMI) undergoing primary percutaneous coronary intervention (PCI).
Methods: From August 1, 2008, to December 31, 2009, one hundred eight patients
who underwent primary PCI with IVUS under diagnosis of STEMI were enrolled in
this study. Fifty four patients (50.0%) showed TP in IVUS after stent implantation.
Clinical characteristics, angiographic and IVUS data were statistically analyzed
according to presence of TP. (TP+ vs. TP-) One month, one year, two years, and three
years clinical follow up was performed.
Results: In TP + group, EF was lower (47.58.0% vs. 52.38.8%, p¼0.004), peak
creatine kinase-myocardial band(CK-MB) level was higher (230.8219.5 mg/dl vs.mber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
